Bespoke Extracts, Inc. (BSPK) financial statements (2022 and earlier)

Company profile

Business Address 2590 WALNUT ST.
DENVER, CO 80205
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6111271080870
Cash and cash equivalents6111271080870
Receivables45462  
Inventory, net of allowances, customer advances and progress billings474811362  
Inventory474811362  
Prepaid expense8242183120 
Other undisclosed current assets  (11)    
Total current assets:6489133381751070
Noncurrent Assets
Property, plant and equipment33     
Intangible assets, net (including goodwill)      1
Intangible assets, net (excluding goodwill)      1
Regulated entity, other noncurrent assets   2,056   
Other undisclosed noncurrent assets 3334(2,014)4549 
Total noncurrent assets:335344245491
TOTAL ASSETS:67125166792201562
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4742601111053769
Other undisclosed accounts payable and accrued liabilities4742601111053769
Debt 500500 461  
Derivative instruments and hedges, liabilities75      
Due to related parties251120004546
Other undisclosed current liabilities     153 
Total current liabilities:147543680111566235116
Noncurrent Liabilities
Long-term debt and lease obligation    81193 
Long-term debt, excluding current maturities    81193 
Total noncurrent liabilities:    81193 
Total liabilities:147543680111647428116
Stockholders' equity
Stockholders' equity attributable to parent, including:(80)(418)(514)(32)(428)(272)(114)
Common stock249247194784327 
Additional paid in capital19,18719,07717,99313,95016,2468,8082,311
Accumulated deficit(19,515)(19,742)(18,777)(14,136)(16,717)(9,107)(2,428)
Other undisclosed stockholders' equity attributable to parent  7676  3
Total stockholders' equity:(80)(418)(514)(32)(428)(272)(114)
TOTAL LIABILITIES AND EQUITY:67125166792201562

Income statement (P&L) ($ in thousands)

11/30/2021
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Revenues   6216  
Cost of revenue
(Cost of Goods and Services Sold)
(13)(14)(4)(71)(23)  
Other undisclosed gross profit32368    
Gross profit:18225(9)(7)  
Operating expenses(850)(988)(4,020)3,024(7,184)(6,616)(365)
Operating income (loss):(831)(966)(4,016)3,014(7,191)(6,616)(365)
Nonoperating income (expense)295 (625)(433)(419)(63) 
Interest and debt expense292 (90)(357)(419)(28)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(244)(966)(4,730)2,223(8,029)(6,707)(365)
Other undisclosed income (loss) from continuing operations before income taxes(292) 9035741928 
Net income (loss) available to common stockholders, diluted:(536)(966)(4,641)2,581(7,610)(6,679)(365)

Comprehensive Income ($ in thousands)

11/30/2021
TTM
8/31/2021
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
Net income (loss):(536)(966)(4,641)2,581(7,610)(6,679)(365)
Comprehensive income (loss), net of tax, attributable to parent:(536)(966)(4,641)2,581(7,610)(6,679)(365)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: